Oxeeco Meditek Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 2.23 M
- Company Age 33 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.50 M
- Satisfied Charges ₹ 1.50 Cr
- Revenue Growth -90.99%
- Profit Growth -98.36%
- Ebitda
- Net Worth 0.04%
- Total Assets -0.25%
About Oxeeco Meditek
Oxeeco Meditek Private Limited (OMPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 October 1991 and has a history of 33 years and three months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.23 M.
The company currently has active open charges totaling ₹5.50 M. The company has closed loans amounting to ₹1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sreedhar Chowdhury, Tejuswini Chowdhury, and Poojita Chowdhury serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33100TG1991PTC013313
-
Company No.
013313
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Oct 1991
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Oxeeco Meditek?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreedhar Chowdhury
|
Director | 28-Jan-1994 | Current |
|
Tejuswini Chowdhury
|
Director | 24-Sep-2009 | Current |
|
Poojita Chowdhury
|
Director | 26-Apr-2007 | Current |
Financial Performance of Oxeeco Meditek.
Oxeeco Meditek Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 90.99% decrease. The company also saw a substantial fall in profitability, with a 98.36% decrease in profit. The company's net worth moved up by a moderate rise of 0.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oxeeco Meditek?
In 2019, Oxeeco Meditek had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Fusion Chemical And Products Pvt LtdSreedhar Chowdhury is a mutual person
-
Oxeeco Technologies Private LimitedSreedhar Chowdhury is a mutual person
-
Incon Engineers LtdSreedhar Chowdhury is a mutual person
-
Fusion Advanced Materials Private LimitedSreedhar Chowdhury is a mutual person
-
-
Charges (Loans)
₹5.50 M
₹15.00 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.55 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jan 1995 | State Bank Of India | ₹5.50 M | Open |
| 07 May 2012 | Karvy Financial Services Limited | ₹1.50 Cr | Satisfied |
How Many Employees Work at Oxeeco Meditek?
Unlock and access historical data on people associated with Oxeeco Meditek, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oxeeco Meditek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oxeeco Meditek's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
